Stocks and InvestingStocks and Investing
Tue, November 8, 2022
Mon, November 7, 2022

Tejas Savant Maintained (ADPT) at Hold with Decreased Target to $16 on, Nov 7th, 2022


Published on 2024-10-27 23:57:56 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Hold with Decreased Target from $17 to $16 on, Nov 7th, 2022.

Tejas has made no other calls on ADPT in the last 4 months.



There are 2 other peers that have a rating on ADPT. Out of the 2 peers that are also analyzing ADPT, 1 agrees with Tejas's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Westenberg of "Piper Sandler" Maintained at Hold with Decreased Target to $7.5 on, Wednesday, October 26th, 2022


This is the rating of the analyst that currently disagrees with Tejas


  • Dan Leonard of "Credit Suisse" Initiated at Sell and Held Target at $8 on, Thursday, August 25th, 2022